drugset / Trial / NCT01003691
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and tolerability of multiple doses of RN6G in subjects with advanced dry, age-related macular degeneration including geographic atrophy.
Timeline
- Start
- 2010-08-05
- Primary completion
- 2013-03-05
- Completion
- 2013-04-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RN6G | Unknown | 5 mg/kg | Intravenous |
| Subject | RN6G | Unknown | 15 mg/kg | Intravenous |